Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Gibb

Showing results (131-140 of 327) with videos related to

Pageof 33
Sort By:
Brain Research|July 22, 1982
Altered neurochemical parameters in the brains of mice (Frings) susceptible to audiogenic seizuresC Bakhit, A K Shenoy, E A Swinyard, et al.
Canadian Journal of Physiology and Pharmacology|October 1, 1987
Effect of catecholamines on porcine Sertoli and Leydig cells in primary cultureG Renier, J Gaulin, W Gibb, et al.
European Journal of Pharmacology|February 14, 1991
Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in neurotensin and dynorphin A systemsM Johnson, L G Bush, J W Gibb, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1987
Effect of methamphetamine on neurotensin concentrations in rat brain regionsA A Letter, K Merchant, J W Gibb, et al.
European Journal of Pharmacology|February 10, 1987
A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated derivativesD M Stone, M Johnson, G R Hanson, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1988
Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamineD M Stone, M Johnson, G R Hanson, et al.
Advances in Pharmacology (San Diego, Calif.)|November 5, 1997
Psychostimulants and neuropeptide responseG R Hanson, J D Wagstaff, K Merchant, et al.
Biochemical Pharmacology|August 17, 1993
Effects of ritanserin on the 3,4-methylenedioxymethamphetamine-induced decrease in striatal serotonin concentration and on the increase in striatal neurotensin and dynorphin A concentrationsM Johnson, L G Bush, G R Hanson, et al.
NIDA Research Monograph|January 1, 1989
Role of dopamine in the neurotoxicity induced by amphetamines and related designer drugsJ W Gibb, D M Stone, M Johnson, et al.
Peptides|November 1, 1986
Comparison of responses by striatonigral substance P and neurokinin A systems to methamphetamine treatmentG R Hanson, A A Letter, K Merchant, et al.
Pageof 33

Showing results (131-140 of 327) with videos related to

Sort By:
Pageof 33
Brain Research|July 22, 1982
Altered neurochemical parameters in the brains of mice (Frings) susceptible to audiogenic seizuresC Bakhit, A K Shenoy, E A Swinyard, et al.
Canadian Journal of Physiology and Pharmacology|October 1, 1987
Effect of catecholamines on porcine Sertoli and Leydig cells in primary cultureG Renier, J Gaulin, W Gibb, et al.
European Journal of Pharmacology|February 14, 1991
Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in neurotensin and dynorphin A systemsM Johnson, L G Bush, J W Gibb, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1987
Effect of methamphetamine on neurotensin concentrations in rat brain regionsA A Letter, K Merchant, J W Gibb, et al.
European Journal of Pharmacology|February 10, 1987
A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated derivativesD M Stone, M Johnson, G R Hanson, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1988
Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamineD M Stone, M Johnson, G R Hanson, et al.
Advances in Pharmacology (San Diego, Calif.)|November 5, 1997
Psychostimulants and neuropeptide responseG R Hanson, J D Wagstaff, K Merchant, et al.
Biochemical Pharmacology|August 17, 1993
Effects of ritanserin on the 3,4-methylenedioxymethamphetamine-induced decrease in striatal serotonin concentration and on the increase in striatal neurotensin and dynorphin A concentrationsM Johnson, L G Bush, G R Hanson, et al.
NIDA Research Monograph|January 1, 1989
Role of dopamine in the neurotoxicity induced by amphetamines and related designer drugsJ W Gibb, D M Stone, M Johnson, et al.
Peptides|November 1, 1986
Comparison of responses by striatonigral substance P and neurokinin A systems to methamphetamine treatmentG R Hanson, A A Letter, K Merchant, et al.
Pageof 33